CLCN2 Clicks with Aldosterone-Producing Adenomas, Too!

Total Page:16

File Type:pdf, Size:1020Kb

CLCN2 Clicks with Aldosterone-Producing Adenomas, Too! 5 181 U I Scholl CLCN2 in aldosterone-producing 181:5 C21–C22 Commentary adenomas CLCN2 clicks with aldosterone-producing adenomas, too! Ute I Scholl1,2,3 1Department of Nephrology and Medical Intensive Care, Charité – Universitätsmedizin Berlin, Corporate Member of Correspondence Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany, 2Berlin should be addressed Institute of Health (BIH), Berlin, Germany, and 3Charité — Universitätsmedizin Berlin, BCRT - BIH Center for to U I Scholl Regenerative Therapies, Berlin, Germany Email [email protected] Abstract Germline mutations in the chloride channel gene CLCN2 have been described as cause of familial hyperaldosteronism type II. In this issue, Dutta and colleagues in a groundbreaking study identify a somatic (tumor-specific)CLCN2 mutation in an aldosterone-producing adenoma, expanding the disease spectrum associated with CLCN2 mutations. European Journal of Endocrinology (2019) 181, C21–C22 In primary aldosteronism, inappropriately elevated (encoding for another calcium channel), have so far aldosterone levels cause hypertension and – as an only been identified in familial hyperaldosteronism 5( ), optional finding – hypokalemia. Contrary to historic raising the question whether do not provide sufficient estimates, primary aldosteronism is now considered the proliferative stimulus for adenoma formation. commonest cause of secondary hypertension, present Most recently, two groups reported germline mutations European Journal of Endocrinology in >5% of hypertensive patients. Patients with primary in the CLCN2 gene in familial hyperaldosteronism. aldosteronism typically either have an aldosterone- The report by Scholl et al. described mutations in eight producing adenoma (a benign tumor of the adrenal families (two de novo, 17 individuals total with CLCN2 cortex) or bilateral adrenal hyperplasia. Rarely, familial mutations) (6) and dubbed the associated syndrome aggregation is observed (‘familial hyperaldosteronism’) (1). familial hyperaldosteronism type II; the study by Genetic studies over the last decade have provided insight Fernandes-Rosa et al. identified onede novo case (7). into the molecular pathogenesis of primary aldosteronism, CLCN2 encodes for the voltage-gated chloride channel identifying new somatic (tumor-specific) mutations in ClC-2, the first anion channel implicated in primary aldosterone-producing adenomas and germline (inherited aldosteronism and hypertension. In both studies, or de novo) mutations in familial hyperaldosteronism. electrophysiology demonstrated that ClC-2 mutations The two genes that are most frequently mutated in in familial hyperaldosteronism cause increased chloride aldosterone-producing adenomas are KCNJ5, encoding permeability. The ensuing cellular depolarization leads for a potassium channel, and CACNA1D, encoding for a to activation of voltage-gated calcium channels, influx of calcium channel. Interestingly, germline mutations in the calcium and increased aldosterone production. same genes can also cause Mendelian forms of primary In a landmark paper in this issue of the European aldosteronism (2, 3). Contrary, mutations in some genes, Journal of Endocrinology, Dutta et al. add an important piece such as ATP1A1 and ATP2B3 encoding ATPases (4), are of the primary aldosteronism genetics puzzle. They Sanger only found in aldosterone-producing adenomas, but not sequenced the CLCN2 coding regions in 80 aldosterone- in familial hyperaldosteronism, likely because germline producing adenomas from Norway, Sweden and Germany mutations would be lethal. Mutations in other genes, (8). One of these tumors carried a somatic CLCN2 mutation. namely CYP11B2 (aldosterone synthase) and CACNA1H Remarkably, this somatic mutation (p.Gly24Asp) was https://eje.bioscientifica.com © 2019 European Society of Endocrinology Published by Bioscientifica Ltd. https://doi.org/10.1530/EJE-19-0688 Printed in Great Britain Downloaded from Bioscientifica.com at 09/30/2021 09:57:29PM via free access -19-0688 Commentary U I Scholl CLCN2 in aldosterone-producing 181:5 C22 adenomas identical with the de novo germline mutation reported in the mutations in aldosterone-producing adenomas (2, 3). patient described by Fernandes-Rosa et al. (7). The tumor Dutta et al. turn the story around, expanding the disease with CLCN2 mutation was 13 mm in size (thus, rather spectrum associated with gain-of-function mutations in small) and was found in a 35-year-old man with elevated CLCN2 from familial hyperaldosteronism to aldosterone- aldosterone levels. Preoperative adrenal venous sampling producing adenomas. demonstrated lateralization of aldosterone production. After surgical tumor removal, both blood pressure and aldosterone:renin ratio normalized. RNA expression levels Declaration of interest Rockefeller University has filed a patent application (PCT/US2018/033362, of CYP11B2 (aldosterone synthase) in the tumor were Compositions and methods for diagnosing and treating diseases and high, providing further evidence that the lesion was the disorders associated with mutant KCNJ5), with UIS as one of the inventors. cause of the patient’s primary aldosteronism. The p.Gly24Asp mutation changes a conserved residue in the N-terminus of the ClC-2 channel. Its impact on Funding This work was supported by grants from the Stiftung Charité (BIH Johanna channel function and aldosterone production has been Quandt Professorship) and the Deutsche Forschungsgemeinschaft (DFG, well studied in vitro. Mutant channels show higher current SCHO 1386/2-1). amplitudes and altered voltage-dependent gating. In a cellular model of glomerulosa function, transfection of channels carrying the mutation significantly raises References aldosterone production compared to wildtype channels (7). 1 Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, Stowasser M & Young WF, Jr. The management of Collectively, there is no doubt that the somatic CLCN2 primary aldosteronism: case detection, diagnosis, and treatment: mutation reported by Dutta et al. accounts for increased an Endocrine Society clinical practice guideline. Journal of Clinical aldosterone production in the tumor. Some open Endocrinology and Metabolism 2016 101 1889–1916. (https://doi. org/10.1210/jc.2015-4061) questions remain: Do CLCN2 mutations cause sufficient 2 Choi M, Scholl UI, Yue P, Bjorklund P, Zhao B, Nelson-Williams C, proliferation to cause tumor formation (as mentioned, Ji W, Cho Y, Patel A, Men CJ et al. K+ channel mutations in the tumor reported by Dutta et al. was quite small) or do adrenal aldosterone-producing adenomas and hereditary hypertension. Science 2011 331 768–772. (https://doi.org/10.1126/ tumors with CLCN2 mutations carry additional somatic science.1198785) mutations that account for proliferation? How frequent 3 Scholl UI, Goh G, Stolting G, de Oliveira RC, Choi M, Overton JD, are somatic CLCN2 mutations in aldosterone-producing Fonseca AL, Korah R, Starker LF, Kunstman JW et al. Somatic and germline CACNA1D calcium channel mutations in aldosterone- adenomas? Are CYP11B2 or CACNA1H mutations also producing adenomas and primary aldosteronism. Nature Genetics European Journal of Endocrinology rare causes of aldosterone-producing adenomas? What 2013 45 1050–1054. (https://doi.org/10.1038/ng.2695) is the phenotype associated with CLCN2 mutations 4 Beuschlein F, Boulkroun S, Osswald A, Wieland T, Nielsen HN, Lichtenauer UD, Penton D, Schack VR, Amar L, Fischer E et al. (e.g. tumors with KCNJ5 mutations are typically large Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone- and associated with female gender)? Exome sequencing producing adenomas and secondary hypertension. Nature Genetics of the tumor with CLCN2 mutation and normal tissue, 2013 45 440–444, 444e1. (https://doi.org/10.1038/ng.2550) 5 Scholl UI, Stolting G, Nelson-Williams C, Vichot AA, Choi M, as well as targeted sequencing of large cohorts could Loring E, Prasad ML, Goh G, Carling T, Juhlin CC et al. Recurrent provide additional insights. In any case, the study by gain of function mutation in calcium channel CACNA1H causes Dutta et al. is a milestone toward the identification early-onset hypertension with primary aldosteronism. ELife 2015 4 e06315. (https://doi.org/10.7554/eLife.06315) of additional rare somatic mutations in aldosterone- 6 Scholl UI, Stolting G, Schewe J, Thiel A, Tan H, Nelson-Williams C, producing adenomas, further emphasizing the long- Vichot AA, Jin SC, Loring E, Untiet V et al. CLCN2 chloride channel neglected role of anion channels in zona glomerulosa mutations in familial hyperaldosteronism type II. Nature Genetics 2018 50 349–354. (https://doi.org/10.1038/s41588-018-0048-5) function and primary aldosteronism. Lastly, it provides 7 Fernandes-Rosa FL, Daniil G, Orozco IJ, Goppner C, El Zein R, Jain V, yet another example of the fruitful interactions between Boulkroun S, Jeunemaitre X, Amar L, Lefebvre H et al. A gain-of- the studies of rare Mendelian diseases (such as familial function mutation in the CLCN2 chloride channel gene causes primary aldosteronism. Nature Genetics 2018 50 355–361. (https:// hyperaldosteronism) and more common sporadic doi.org/10.1038/s41588-018-0053-8) disorders (such as aldosterone-producing adenomas): 8 Dutta RK, Arnesen T, Heie A, Walz M, Alesina P, Söderkvist P & The identification of germline mutations in the KCNJ5 Gimm O. Case report: a somatic mutation in CLCN2 identified in a sporadic aldosterone producing adenoma. European Journal of and the CACNA1D genes in familial hyperaldosteronism Endocrinology 2019 181 K37–K41. (https://doi.org/10.1530/EJE-19- was inspired by the discovery of corresponding somatic 0377) Received 26 August 2019 Accepted 6 September 2019 https://eje.bioscientifica.com Downloaded from Bioscientifica.com at 09/30/2021 09:57:29PM via free access.
Recommended publications
  • The Mineralocorticoid Receptor Leads to Increased Expression of EGFR
    www.nature.com/scientificreports OPEN The mineralocorticoid receptor leads to increased expression of EGFR and T‑type calcium channels that support HL‑1 cell hypertrophy Katharina Stroedecke1,2, Sandra Meinel1,2, Fritz Markwardt1, Udo Kloeckner1, Nicole Straetz1, Katja Quarch1, Barbara Schreier1, Michael Kopf1, Michael Gekle1 & Claudia Grossmann1* The EGF receptor (EGFR) has been extensively studied in tumor biology and recently a role in cardiovascular pathophysiology was suggested. The mineralocorticoid receptor (MR) is an important efector of the renin–angiotensin–aldosterone‑system and elicits pathophysiological efects in the cardiovascular system; however, the underlying molecular mechanisms are unclear. Our aim was to investigate the importance of EGFR for MR‑mediated cardiovascular pathophysiology because MR is known to induce EGFR expression. We identifed a SNP within the EGFR promoter that modulates MR‑induced EGFR expression. In RNA‑sequencing and qPCR experiments in heart tissue of EGFR KO and WT mice, changes in EGFR abundance led to diferential expression of cardiac ion channels, especially of the T‑type calcium channel CACNA1H. Accordingly, CACNA1H expression was increased in WT mice after in vivo MR activation by aldosterone but not in respective EGFR KO mice. Aldosterone‑ and EGF‑responsiveness of CACNA1H expression was confrmed in HL‑1 cells by Western blot and by measuring peak current density of T‑type calcium channels. Aldosterone‑induced CACNA1H protein expression could be abrogated by the EGFR inhibitor AG1478. Furthermore, inhibition of T‑type calcium channels with mibefradil or ML218 reduced diameter, volume and BNP levels in HL‑1 cells. In conclusion the MR regulates EGFR and CACNA1H expression, which has an efect on HL‑1 cell diameter, and the extent of this regulation seems to depend on the SNP‑216 (G/T) genotype.
    [Show full text]
  • Supplementary Table 1. Pain and PTSS Associated Genes (N = 604
    Supplementary Table 1. Pain and PTSS associated genes (n = 604) compiled from three established pain gene databases (PainNetworks,[61] Algynomics,[52] and PainGenes[42]) and one PTSS gene database (PTSDgene[88]). These genes were used in in silico analyses aimed at identifying miRNA that are predicted to preferentially target this list genes vs. a random set of genes (of the same length). ABCC4 ACE2 ACHE ACPP ACSL1 ADAM11 ADAMTS5 ADCY5 ADCYAP1 ADCYAP1R1 ADM ADORA2A ADORA2B ADRA1A ADRA1B ADRA1D ADRA2A ADRA2C ADRB1 ADRB2 ADRB3 ADRBK1 ADRBK2 AGTR2 ALOX12 ANO1 ANO3 APOE APP AQP1 AQP4 ARL5B ARRB1 ARRB2 ASIC1 ASIC2 ATF1 ATF3 ATF6B ATP1A1 ATP1B3 ATP2B1 ATP6V1A ATP6V1B2 ATP6V1G2 AVPR1A AVPR2 BACE1 BAMBI BDKRB2 BDNF BHLHE22 BTG2 CA8 CACNA1A CACNA1B CACNA1C CACNA1E CACNA1G CACNA1H CACNA2D1 CACNA2D2 CACNA2D3 CACNB3 CACNG2 CALB1 CALCRL CALM2 CAMK2A CAMK2B CAMK4 CAT CCK CCKAR CCKBR CCL2 CCL3 CCL4 CCR1 CCR7 CD274 CD38 CD4 CD40 CDH11 CDK5 CDK5R1 CDKN1A CHRM1 CHRM2 CHRM3 CHRM5 CHRNA5 CHRNA7 CHRNB2 CHRNB4 CHUK CLCN6 CLOCK CNGA3 CNR1 COL11A2 COL9A1 COMT COQ10A CPN1 CPS1 CREB1 CRH CRHBP CRHR1 CRHR2 CRIP2 CRYAA CSF2 CSF2RB CSK CSMD1 CSNK1A1 CSNK1E CTSB CTSS CX3CL1 CXCL5 CXCR3 CXCR4 CYBB CYP19A1 CYP2D6 CYP3A4 DAB1 DAO DBH DBI DICER1 DISC1 DLG2 DLG4 DPCR1 DPP4 DRD1 DRD2 DRD3 DRD4 DRGX DTNBP1 DUSP6 ECE2 EDN1 EDNRA EDNRB EFNB1 EFNB2 EGF EGFR EGR1 EGR3 ENPP2 EPB41L2 EPHB1 EPHB2 EPHB3 EPHB4 EPHB6 EPHX2 ERBB2 ERBB4 EREG ESR1 ESR2 ETV1 EZR F2R F2RL1 F2RL2 FAAH FAM19A4 FGF2 FKBP5 FLOT1 FMR1 FOS FOSB FOSL2 FOXN1 FRMPD4 FSTL1 FYN GABARAPL1 GABBR1 GABBR2 GABRA2 GABRA4
    [Show full text]
  • Phenotypic Spectrum and Long-Term Outcome in Children with Genetic Causes of Early-Onset Epileptic Encephalopathy
    Phenotypic Spectrum and Long-term Outcome in Children With Genetic Causes of Early-onset Epileptic Encephalopathy Chunhui Hu Department of Neurology, Children’s Hospital of Fudan University Deying Liu Wuhan Children’s hospital, Tongji Medical college, Huazhong University of Science & Technology Tian Luo Department of Neurology, Children’s Hospital of Fudan University Yi Wang ( [email protected] ) Department of Neurology, Children’s Hospital of Fudan University Zhisheng Liu Wuhan Children’s hospital, Tongji Medical college, Huazhong University of Science & Technology Research Article Keywords: Phenotypic spectrum, Long-term outcome, Genetic, EOEE, Therapy Posted Date: March 11th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-257334/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/23 Abstract Background To explore the clinical phenotype and long-term outcome in children with genetic causes of early-onset epileptic encephalopathies. Methods The clinical data of 118 children between 2010 and 2020 was obtained and analyzed. The whole exome sequencing and copy number variation studies in family were used to nd pathogenic mutations. The conrmed mutations were veried by Sanger sequencing. Results Among 118 patients, 39 patients were diagnosed with DS, 18 were WS, 3 were OS, 3 were EME, 2 were MMFSI, 1 was GLUT1 deciency syndrome, 1 was Pyridoxine dependent epilepsy and 51 were non-symptomatic EOEEs. The initial EEG showed frequent multiple and multifocal sharp waves, spike waves, sharp slow waves or spike slow waves. In the later period, some transformed into infrequent discharging or normal EEG. 112 patients (112/118, 94.9%) showed normal brain MRI, and the remaining 6 had widened extracerebral space.
    [Show full text]
  • An Advance About the Genetic Causes of Epilepsy
    E3S Web of Conferences 271, 03068 (2021) https://doi.org/10.1051/e3sconf/202127103068 ICEPE 2021 An advance about the genetic causes of epilepsy Yu Sun1, a, *, †, Licheng Lu2, b, *, †, Lanxin Li3, c, *, †, Jingbo Wang4, d, *, † 1The School of Molecular and Cellular Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801-3633, US 2High School Affiliated to Shanghai Jiao Tong University, Shanghai, 200441, China 3Applied Biology program, University of British Columbia, Vancouver, V6r3b1, Canada 4School of Chemical Machinery and Safety, Dalian University of Technology, Dalian, 116023, China †These authors contributed equally. Abstract: Human hereditary epilepsy has been found related to ion channel mutations in voltage-gated channels (Na+, K+, Ca2+, Cl-), ligand gated channels (GABA receptors), and G-protein coupled receptors, such as Mass1. In addition, some transmembrane proteins or receptor genes, including PRRT2 and nAChR, and glucose transporter genes, such as GLUT1 and SLC2A1, are also about the onset of epilepsy. The discovery of these genetic defects has contributed greatly to our understanding of the pathology of epilepsy. This review focuses on introducing and summarizing epilepsy-associated genes and related findings in recent decades, pointing out related mutant genes that need to be further studied in the future. 1 Introduction Epilepsy is a neurological disorder characterized by 2 Malfunction of Ion channel epileptic seizures caused by abnormal brain activity. 1 in Functional variation in voltage or ligand-gated ion 100 (50 million people) people are affected by symptoms channel mutations is a major cause of idiopathic epilepsy, of this disorder worldwide, with men, young children, and especially in rare genetic forms.
    [Show full text]
  • Transcriptomic Profiling of Ca Transport Systems During
    cells Article Transcriptomic Profiling of Ca2+ Transport Systems during the Formation of the Cerebral Cortex in Mice Alexandre Bouron Genetics and Chemogenomics Lab, Université Grenoble Alpes, CNRS, CEA, INSERM, Bâtiment C3, 17 rue des Martyrs, 38054 Grenoble, France; [email protected] Received: 29 June 2020; Accepted: 24 July 2020; Published: 29 July 2020 Abstract: Cytosolic calcium (Ca2+) transients control key neural processes, including neurogenesis, migration, the polarization and growth of neurons, and the establishment and maintenance of synaptic connections. They are thus involved in the development and formation of the neural system. In this study, a publicly available whole transcriptome sequencing (RNA-Seq) dataset was used to examine the expression of genes coding for putative plasma membrane and organellar Ca2+-transporting proteins (channels, pumps, exchangers, and transporters) during the formation of the cerebral cortex in mice. Four ages were considered: embryonic days 11 (E11), 13 (E13), and 17 (E17), and post-natal day 1 (PN1). This transcriptomic profiling was also combined with live-cell Ca2+ imaging recordings to assess the presence of functional Ca2+ transport systems in E13 neurons. The most important Ca2+ routes of the cortical wall at the onset of corticogenesis (E11–E13) were TACAN, GluK5, nAChR β2, Cav3.1, Orai3, transient receptor potential cation channel subfamily M member 7 (TRPM7) non-mitochondrial Na+/Ca2+ exchanger 2 (NCX2), and the connexins CX43/CX45/CX37. Hence, transient receptor potential cation channel mucolipin subfamily member 1 (TRPML1), transmembrane protein 165 (TMEM165), and Ca2+ “leak” channels are prominent intracellular Ca2+ pathways. The Ca2+ pumps sarco/endoplasmic reticulum Ca2+ ATPase 2 (SERCA2) and plasma membrane Ca2+ ATPase 1 (PMCA1) control the resting basal Ca2+ levels.
    [Show full text]
  • Transcriptomic Uniqueness and Commonality of the Ion Channels and Transporters in the Four Heart Chambers Sanda Iacobas1, Bogdan Amuzescu2 & Dumitru A
    www.nature.com/scientificreports OPEN Transcriptomic uniqueness and commonality of the ion channels and transporters in the four heart chambers Sanda Iacobas1, Bogdan Amuzescu2 & Dumitru A. Iacobas3,4* Myocardium transcriptomes of left and right atria and ventricles from four adult male C57Bl/6j mice were profled with Agilent microarrays to identify the diferences responsible for the distinct functional roles of the four heart chambers. Female mice were not investigated owing to their transcriptome dependence on the estrous cycle phase. Out of the quantifed 16,886 unigenes, 15.76% on the left side and 16.5% on the right side exhibited diferential expression between the atrium and the ventricle, while 5.8% of genes were diferently expressed between the two atria and only 1.2% between the two ventricles. The study revealed also chamber diferences in gene expression control and coordination. We analyzed ion channels and transporters, and genes within the cardiac muscle contraction, oxidative phosphorylation, glycolysis/gluconeogenesis, calcium and adrenergic signaling pathways. Interestingly, while expression of Ank2 oscillates in phase with all 27 quantifed binding partners in the left ventricle, the percentage of in-phase oscillating partners of Ank2 is 15% and 37% in the left and right atria and 74% in the right ventricle. The analysis indicated high interventricular synchrony of the ion channels expressions and the substantially lower synchrony between the two atria and between the atrium and the ventricle from the same side. Starting with crocodilians, the heart pumps the blood through the pulmonary circulation and the systemic cir- culation by the coordinated rhythmic contractions of its upper lef and right atria (LA, RA) and lower lef and right ventricles (LV, RV).
    [Show full text]
  • Identification of Key Pathways and Genes in Dementia Via Integrated Bioinformatics Analysis
    bioRxiv preprint doi: https://doi.org/10.1101/2021.04.18.440371; this version posted July 19, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Identification of Key Pathways and Genes in Dementia via Integrated Bioinformatics Analysis Basavaraj Vastrad1, Chanabasayya Vastrad*2 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karnataka, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India bioRxiv preprint doi: https://doi.org/10.1101/2021.04.18.440371; this version posted July 19, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract To provide a better understanding of dementia at the molecular level, this study aimed to identify the genes and key pathways associated with dementia by using integrated bioinformatics analysis. Based on the expression profiling by high throughput sequencing dataset GSE153960 derived from the Gene Expression Omnibus (GEO), the differentially expressed genes (DEGs) between patients with dementia and healthy controls were identified. With DEGs, we performed a series of functional enrichment analyses. Then, a protein–protein interaction (PPI) network, modules, miRNA-hub gene regulatory network and TF-hub gene regulatory network was constructed, analyzed and visualized, with which the hub genes miRNAs and TFs nodes were screened out. Finally, validation of hub genes was performed by using receiver operating characteristic curve (ROC) analysis.
    [Show full text]
  • A Rare CACNA1H Variant Associated with Amyotrophic Lateral Sclerosis Causes Complete Loss of Cav3.2 T-Type Channel Activity Robin N
    Stringer et al. Molecular Brain (2020) 13:33 https://doi.org/10.1186/s13041-020-00577-6 RESEARCH Open Access A rare CACNA1H variant associated with amyotrophic lateral sclerosis causes complete loss of Cav3.2 T-type channel activity Robin N. Stringer1,2, Bohumila Jurkovicova-Tarabova3, Sun Huang4, Omid Haji-Ghassemi5, Romane Idoux1, Anna Liashenko1, Ivana A. Souza4, Yuriy Rzhepetskyy1, Lubica Lacinova3, Filip Van Petegem5, Gerald W. Zamponi4, Roger Pamphlett6 and Norbert Weiss1* Abstract Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterized by the progressive loss of cortical, brain stem and spinal motor neurons that leads to muscle weakness and death. A previous study implicated CACN A1H encoding for Cav3.2 calcium channels as a susceptibility gene in ALS. In the present study, two heterozygous CACNA1H variants were identified by whole genome sequencing in a small cohort of ALS patients. These variants were functionally characterized using patch clamp electrophysiology, biochemistry assays, and molecular modeling. A previously unreported c.454GTAC > G variant produced an inframe deletion of a highly conserved isoleucine residue in Cav3.2 (p.ΔI153) and caused a complete loss-of-function of the channel, with an additional dominant- negative effect on the wild-type channel when expressed in trans. In contrast, the c.3629C > T variant caused a missense substitution of a proline with a leucine (p.P1210L) and produced a comparatively mild alteration of Cav3.2 channel activity. The newly identified ΔI153 variant is the first to be reported to cause a complete loss of Cav3.2 channel function. These findings add to the notion that loss-of-function of Cav3.2 channels associated with rare CACNA1H variants may be risk factors in the complex etiology of ALS.
    [Show full text]
  • Human Induced Pluripotent Stem Cell–Derived Podocytes Mature Into Vascularized Glomeruli Upon Experimental Transplantation
    BASIC RESEARCH www.jasn.org Human Induced Pluripotent Stem Cell–Derived Podocytes Mature into Vascularized Glomeruli upon Experimental Transplantation † Sazia Sharmin,* Atsuhiro Taguchi,* Yusuke Kaku,* Yasuhiro Yoshimura,* Tomoko Ohmori,* ‡ † ‡ Tetsushi Sakuma, Masashi Mukoyama, Takashi Yamamoto, Hidetake Kurihara,§ and | Ryuichi Nishinakamura* *Department of Kidney Development, Institute of Molecular Embryology and Genetics, and †Department of Nephrology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; ‡Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima, Japan; §Division of Anatomy, Juntendo University School of Medicine, Tokyo, Japan; and |Japan Science and Technology Agency, CREST, Kumamoto, Japan ABSTRACT Glomerular podocytes express proteins, such as nephrin, that constitute the slit diaphragm, thereby contributing to the filtration process in the kidney. Glomerular development has been analyzed mainly in mice, whereas analysis of human kidney development has been minimal because of limited access to embryonic kidneys. We previously reported the induction of three-dimensional primordial glomeruli from human induced pluripotent stem (iPS) cells. Here, using transcription activator–like effector nuclease-mediated homologous recombination, we generated human iPS cell lines that express green fluorescent protein (GFP) in the NPHS1 locus, which encodes nephrin, and we show that GFP expression facilitated accurate visualization of nephrin-positive podocyte formation in
    [Show full text]
  • Co-Expression Network of Neural-Differentiation Genes Shows
    Maschietto et al. BMC Medical Genomics (2015) 8:23 DOI 10.1186/s12920-015-0098-9 RESEARCH ARTICLE Open Access Co-expression network of neural-differentiation genes shows specific pattern in schizophrenia Mariana Maschietto1,2†, Ana C Tahira1,2†, Renato Puga3, Leandro Lima4, Daniel Mariani4, Bruna da Silveira Paulsen5, Paulo Belmonte-de-Abreu6, Henrique Vieira4, Ana CV Krepischi7, Dirce M Carraro8, Joana A Palha9,10, Stevens Rehen5,11 and Helena Brentani1,2,12,13* Abstract Background: Schizophrenia is a neurodevelopmental disorder with genetic and environmental factors contributing to its pathogenesis, although the mechanism is unknown due to the difficulties in accessing diseased tissue during human neurodevelopment. The aim of this study was to find neuronal differentiation genes disrupted in schizophrenia and to evaluate those genes in post-mortem brain tissues from schizophrenia cases and controls. Methods: We analyzed differentially expressed genes (DEG), copy number variation (CNV) and differential methylation in human induced pluripotent stem cells (hiPSC) derived from fibroblasts from one control and one schizophrenia patient and further differentiated into neuron (NPC). Expression of the DEG were analyzed with microarrays of post-mortem brain tissue (frontal cortex) cohort of 29 schizophrenia cases and 30 controls. A Weighted Gene Co-expression Network Analysis (WGCNA) using the DEG was used to detect clusters of co-expressed genes that werenon-conserved between adult cases and controls brain samples. Results: We identified methylation alterations potentially involved with neuronal differentiation in schizophrenia, which displayed an over-representation of genes related to chromatin remodeling complex (adjP = 0.04). We found 228 DEG associated with neuronal differentiation.
    [Show full text]
  • 1 1 2 3 Cell Type-Specific Transcriptomics of Hypothalamic
    1 2 3 4 Cell type-specific transcriptomics of hypothalamic energy-sensing neuron responses to 5 weight-loss 6 7 Fredrick E. Henry1,†, Ken Sugino1,†, Adam Tozer2, Tiago Branco2, Scott M. Sternson1,* 8 9 1Janelia Research Campus, Howard Hughes Medical Institute, 19700 Helix Drive, Ashburn, VA 10 20147, USA. 11 2Division of Neurobiology, Medical Research Council Laboratory of Molecular Biology, 12 Cambridge CB2 0QH, UK 13 14 †Co-first author 15 *Correspondence to: [email protected] 16 Phone: 571-209-4103 17 18 Authors have no competing interests 19 1 20 Abstract 21 Molecular and cellular processes in neurons are critical for sensing and responding to energy 22 deficit states, such as during weight-loss. AGRP neurons are a key hypothalamic population 23 that is activated during energy deficit and increases appetite and weight-gain. Cell type-specific 24 transcriptomics can be used to identify pathways that counteract weight-loss, and here we 25 report high-quality gene expression profiles of AGRP neurons from well-fed and food-deprived 26 young adult mice. For comparison, we also analyzed POMC neurons, an intermingled 27 population that suppresses appetite and body weight. We find that AGRP neurons are 28 considerably more sensitive to energy deficit than POMC neurons. Furthermore, we identify cell 29 type-specific pathways involving endoplasmic reticulum-stress, circadian signaling, ion 30 channels, neuropeptides, and receptors. Combined with methods to validate and manipulate 31 these pathways, this resource greatly expands molecular insight into neuronal regulation of 32 body weight, and may be useful for devising therapeutic strategies for obesity and eating 33 disorders.
    [Show full text]
  • Graded Co-Expression of Ion Channel, Neurofilament, and Synaptic Genes in Fast- Spiking Vestibular Nucleus Neurons
    Research Articles: Cellular/Molecular Graded co-expression of ion channel, neurofilament, and synaptic genes in fast- spiking vestibular nucleus neurons https://doi.org/10.1523/JNEUROSCI.1500-19.2019 Cite as: J. Neurosci 2019; 10.1523/JNEUROSCI.1500-19.2019 Received: 26 June 2019 Revised: 11 October 2019 Accepted: 25 October 2019 This Early Release article has been peer-reviewed and accepted, but has not been through the composition and copyediting processes. The final version may differ slightly in style or formatting and will contain links to any extended data. Alerts: Sign up at www.jneurosci.org/alerts to receive customized email alerts when the fully formatted version of this article is published. Copyright © 2019 the authors 1 Graded co-expression of ion channel, neurofilament, and synaptic genes in fast-spiking 2 vestibular nucleus neurons 3 4 Abbreviated title: A fast-spiking gene module 5 6 Takashi Kodama1, 2, 3, Aryn Gittis, 3, 4, 5, Minyoung Shin2, Keith Kelleher2, 3, Kristine Kolkman3, 4, 7 Lauren McElvain3, 4, Minh Lam1, and Sascha du Lac1, 2, 3 8 9 1 Johns Hopkins University School of Medicine, Baltimore MD, 21205 10 2 Howard Hughes Medical Institute, La Jolla, CA, 92037 11 3 Salk Institute for Biological Studies, La Jolla, CA, 92037 12 4 Neurosciences Graduate Program, University of California San Diego, La Jolla, CA, 92037 13 5 Carnegie Mellon University, Pittsburgh, PA, 15213 14 15 Corresponding Authors: 16 Takashi Kodama ([email protected]) 17 Sascha du Lac ([email protected]) 18 Department of Otolaryngology-Head and Neck Surgery 19 The Johns Hopkins University School of Medicine 20 Ross Research Building 420, 720 Rutland Avenue, Baltimore, Maryland, 21205 21 22 23 Conflict of Interest 24 The authors declare no competing financial interests.
    [Show full text]